Literature DB >> 15902771

Type 2 diabetes market.

Leland Gershell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15902771     DOI： 10.1038/nrd1723

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  10 in total

Review 1.  The burden and risks of emerging complications of diabetes mellitus.

Authors:  Dunya Tomic; Jonathan E Shaw; Dianna J Magliano
Journal:  Nat Rev Endocrinol       Date:  2022-06-06       Impact factor: 47.564

2.  Comparative docking assessment of glucokinase interactions with its allosteric activators.

Authors:  Vandana Kumari; Chenglong Li
Journal:  Curr Chem Genomics       Date:  2008-12-30

3.  Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions.

Authors:  M C T Fyfe; J R White; A Taylor; R Chatfield; E Wargent; R L Printz; T Sulpice; J G McCormack; M J Procter; C Reynet; P S Widdowson; P Wong-Kai-In
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122

4.  The Glucose Lowering Effect of Zornia gibbosa Span Extracts in Diabetic Rats.

Authors:  Mallikarjuna Rao Talluri; Rajananda Swamy Tadi; Ganga Rao Battu; Mohammad Zubair
Journal:  Turk J Pharm Sci       Date:  2018-11-20

5.  α-glucosidase inhibitors from plants: A natural approach to treat diabetes.

Authors:  Sunil Kumar; Smita Narwal; Vipin Kumar; Om Prakash
Journal:  Pharmacogn Rev       Date:  2011-01

Review 6.  Antidiabetic Effects of Aronia melanocarpa and Its Other Therapeutic Properties.

Authors:  Ines Banjari; Andreja Misir; Katarina Šavikin; Stela Jokić; Maja Molnar; H K S De Zoysa; Viduranga Y Waisundara
Journal:  Front Nutr       Date:  2017-11-06

7.  Protein Tyrosine Phosphatase 1B Inhibition and Glucose Uptake Potentials of Mulberrofuran G, Albanol B, and Kuwanon G from Root Bark of Morus alba L. in Insulin-Resistant HepG2 Cells: An In Vitro and In Silico Study.

Authors:  Pradeep Paudel; Ting Yu; Su Hui Seong; Eun Bi Kuk; Hyun Ah Jung; Jae Sue Choi
Journal:  Int J Mol Sci       Date:  2018-05-22       Impact factor: 5.923

8.  Novel Mixed-Type Inhibitors of Protein Tyrosine Phosphatase 1B. Kinetic and Computational Studies.

Authors:  Marie Jazmín Sarabia-Sánchez; Pedro Josué Trejo-Soto; José Miguel Velázquez-López; Carlos Carvente-García; Rafael Castillo; Alicia Hernández-Campos; Claudia Avitia-Domínguez; Daniel Enríquez-Mendiola; Erick Sierra-Campos; Mónica Valdez-Solana; José Manuel Salas-Pacheco; Alfredo Téllez-Valencia
Journal:  Molecules       Date:  2017-12-20       Impact factor: 4.411

9.  Crude extract and isolated bioactive compounds from Notholirion thomsonianum (Royale) Stapf as multitargets antidiabetic agents: in-vitro and molecular docking approaches.

Authors:  Mater H Mahnashi; Yahya S Alqahtani; Ali O Alqarni; Bandar A Alyami; Muhammad Saeed Jan; Muhammad Ayaz; Farhat Ullah; Umer Rashid; Abdul Sadiq
Journal:  BMC Complement Med Ther       Date:  2021-10-27

Review 10.  A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy.

Authors:  Michelle Orme; Peter Fenici; Isabelle Duprat Lomon; Gail Wygant; Rebecca Townsend; Marina Roudaut
Journal:  Diabetol Metab Syndr       Date:  2014-06-11       Impact factor: 3.320
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.